Business Wire11.14.16
Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced Ted Bird has joined the executive management team as Chief Commercial Officer (CCO). Mr. Bird will be responsible for the Company’s global sales, marketing, strategic partnering, and national target accounts.
Peter Ullrich, CEO of Titan Spine, commented, “Ted is a well-respected medical device commercial leader with more than 30 years of sales, marketing and senior executive experience at leading healthcare companies. He is well-known and highly regarded in the spine industry, with extensive relationships among surgeons and distributors built from over 25 years working with spine companies including ApiFix, Orthofix, Depuy Spine and Medtronic Sofamor Danek. We look forward to Ted’s significant spine commercialization expertise and contributions as Titan Spine continues ramping up its full U.S. launch of our Endoskeleton titanium implants featuring our groundbreaking nanoLOCK surface technology, the only nano-cleared interbody device on the market shown to elicit a nano-cellular level response for bone growth.”
Mr. Bird added, “I am incredibly excited and honored to be joining the Titan Spine team. The company has been at the forefront of moving the interbody device marketplace away from PEEK and towards titanium surface-enhanced implants for improved patient outcomes with validated, peer-reviewed science and strong support from surgeons, hospitals and the U.S. government. I look forward to working closely with the talented team at Titan Spine to continue building on the positive momentum that the company continues to generate and help lead the next phase of the company’s evolution and growth.”
Peter Ullrich, CEO of Titan Spine, commented, “Ted is a well-respected medical device commercial leader with more than 30 years of sales, marketing and senior executive experience at leading healthcare companies. He is well-known and highly regarded in the spine industry, with extensive relationships among surgeons and distributors built from over 25 years working with spine companies including ApiFix, Orthofix, Depuy Spine and Medtronic Sofamor Danek. We look forward to Ted’s significant spine commercialization expertise and contributions as Titan Spine continues ramping up its full U.S. launch of our Endoskeleton titanium implants featuring our groundbreaking nanoLOCK surface technology, the only nano-cleared interbody device on the market shown to elicit a nano-cellular level response for bone growth.”
Mr. Bird added, “I am incredibly excited and honored to be joining the Titan Spine team. The company has been at the forefront of moving the interbody device marketplace away from PEEK and towards titanium surface-enhanced implants for improved patient outcomes with validated, peer-reviewed science and strong support from surgeons, hospitals and the U.S. government. I look forward to working closely with the talented team at Titan Spine to continue building on the positive momentum that the company continues to generate and help lead the next phase of the company’s evolution and growth.”